Stock A041830 INBODY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings InBody Co.,Ltd

Equities

A041830

KR7041830001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 21/05/2024 BST 		5-day change 1st Jan Change
26,600 KRW -0.93% Intraday chart for InBody Co.,Ltd -2.92% +4.93%
2023 InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 InBody Releases BPBIO 220 and BPBIO 250 CI

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -99% by 2026.
  • The group's high margin levels account for strong profits.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Sales forecast by analysts have been recently revised upwards.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company is not the most generous with respect to shareholders' compensation.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
INBODY CO.,LTD Stock InBody Co.,Ltd
+4.93% 257M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.71% 225B
B
DANAHER CORPORATION Stock Danaher Corporation
+15.92% 197B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+19.51% 143B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.76% 111B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.62% 64.72B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.11% 54.44B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.96% 51.06B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+10.57% 45.03B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+4.99% 37.4B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A041830 Stock
  4. Ratings InBody Co.,Ltd